CUE (STOCKS)
Cue Biopharma, Inc.
$0.327900
-0.009500 (-2.82%)
Prev close: $0.337400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Usman Azam
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $31.06M
- Employees
- 41
- P/E (TTM)
- -0.74
- P/B (TTM)
- 1.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.07 | $-0.09 | +0.0243 | +25.77% |
|
Jun 2025 (Q2)
|
$-0.09 | $-0.14 | +0.0514 | +36.35% |
|
Mar 2025 (Q1)
|
$-0.17 | $-0.15 | -0.0151 | -9.75% |
|
Dec 2024 (Q4)
|
$-0.13 | $-0.16 | +0.0276 | +17.51% |
Financial Statements
| Revenues | $7.10M |
| Benefits Costs and Expenses | $44.78M |
| Costs And Expenses | $44.78M |
| Nonoperating Income/Loss | $480.00K |
| Operating Expenses | $45.26M |
| Depreciation and Amortization | $378.00K |
| Research and Development | $28.40M |
| Other Operating Expenses | $16.49M |
| Operating Income/Loss | -$38.16M |
| Income/Loss From Continuing Operations After Tax | -$37.68M |
| Income/Loss From Continuing Operations Before Tax | -$37.68M |
| Interest Income/Expense After Provision For Losses | -$401.00K |
| Interest Income/Expense Operating, Net | -$459.00K |
| Net Income/Loss | -$37.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$37.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$37.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$0.43 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 276,618,815 |
| Diluted Average Shares | 276,618,815 |
| Assets | $31.64M |
| Current Assets | $25.82M |
| Noncurrent Assets | $5.83M |
| Fixed Assets | $307.00K |
| Other Non-current Assets | $5.52M |
| Liabilities | $18.40M |
| Current Liabilities | $15.52M |
| Accounts Payable | $2.35M |
| Other Current Liabilities | $13.18M |
| Noncurrent Liabilities | $2.87M |
| Equity | $13.25M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.25M |
| Liabilities And Equity | $31.64M |
| Net Cash Flow From Operating Activities | -$29.64M |
| Net Cash Flow From Operating Activities, Continuing | -$29.64M |
| Net Cash Flow From Investing Activities | -$6.95M |
| Net Cash Flow From Investing Activities, Continuing | -$6.95M |
| Net Cash Flow From Financing Activities | $15.87M |
| Net Cash Flow From Financing Activities, Continuing | $15.87M |
| Net Cash Flow | -$20.72M |
| Net Cash Flow, Continuing | -$20.72M |
| Comprehensive Income/Loss | -$37.68M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$37.68M |
| Other Comprehensive Income/Loss | $1.00K |